Open access · US-GOV via ClinicalTrials.gov Clinical trial

Acute Bioavailability of Berry Flavonoids and Impact on Inflammatory Biomarkers in Older Adults With Minor Depressive Symptoms: A Pilot Study

Authors not listed

Hebrew SeniorLife · 2023

Chronic inflammation Human Randomized controlled trial

Abstract

This randomized, cross-over, pilot study aims to compare preliminary impact of a standard dose of blueberry powder (24 g) vs a higher dose (48 g) on the bioavailability of flavonoids and inflammatory biomarkers in older adults with minor levels of depressive symptoms.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-29 MST

Cite this

APA

Anonymous. (2023). Acute Bioavailability of Berry Flavonoids and Impact on Inflammatory Biomarkers in Older Adults With Minor Depressive Symptoms: A Pilot Study. <em>Hebrew SeniorLife</em>. https://clinicaltrials.gov/study/NCT05937165

Vancouver

Anonymous. Acute Bioavailability of Berry Flavonoids and Impact on Inflammatory Biomarkers in Older Adults With Minor Depressive Symptoms: A Pilot Study. Hebrew SeniorLife. 2023.

BibTeX

@misc{anon2023AcuteB, title = {Acute Bioavailability of Berry Flavonoids and Impact on Inflammatory Biomarkers in Older Adults With Minor Depressive Symptoms: A Pilot Study}, author = {Anonymous}, journal = {Hebrew SeniorLife}, year = {2023}, }